PRCT - PROCEPT BioRobotics Corporation
NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors of the September 22, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts. The lawsuit seeks to represent investors who purchased or otherwise acquired PROCEPT common stock between February 28, 2024 and February 25, 2026.
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
San Diego, California--(Newsfile Corp. - September 8, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should be aware of the upcoming September 22, 2026, deadline to seek appointment as lead plaintiff.
New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in PROCEPT and have suffered losses, you may CLICK HERE to contact us.
Important Notice Regarding Alleged Channel Stuffing Misrepresentations: The action claims Procept's undisclosed bulk handpiece discount program pulled forward demand, inflated reported operating metrics, and left PRCT investors facing more than $75.00 per-share losses Important Notice Regarding Alleged Channel Stuffing Misrepresentations: The action claims Procept's undisclosed bulk handpiece discount program pulled forward demand, inflated reported operating metrics, and left PRCT investors facing more than $75.00 per-share losses
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) of the September 22, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
LOS ANGELES, Sept. 8, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action La
LOS ANGELES, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming September 22, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) securities between February 28, 2024 and February 25, 2026 inclusive (the “Class Period”).
SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts.
New York, New York--(Newsfile Corp. - September 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
LOS ANGELES, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
New York, New York--(Newsfile Corp. - September 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Sept. 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
NEW YORK, Sept. 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline.
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Actio